Dentsply Sirona today announced that Richard Rosenzweig has been appointed Senior Vice President (SVP), Corporate Development, General Counsel and Secretary, effective February 27, 2023. In this role he also takes on responsibility for Compliance, Corporate Development and Strategy and becomes a member of the Management Team reporting to the CEO.
Simon Campion, Chief Executive Officer of Dentsply Sirona, said, “We are pleased to have Richard with his diverse leadership experience and a 25-year track record in healthcare join us. As a strong, collaborative leader with seasoned skills in building teams and setting and executing strategies, he will strengthen our Management Team during a phase of organizational changes. Richard adds valuable additional experience with his record of delivering excellent results, including in complex strategic initiatives, transactions and disputes. He also brings critical in-depth governance & compliance expertise.”
Richard Rosenzweig said, “It’s an honor to join Dentsply Sirona as a leading healthcare company and global leader in the dental industry. I share the same values and I am convinced that with the strong team, operational excellence, and a strong focus on accountability we can unlock the full potential of Dentsply Sirona globally. I look forward to partnering with the Management Team on the important mission to transform dentistry to improve oral health globally.”
About Richard Rosenzweig
Most recently, Richard Rosenzweig served as Senior Vice President, General Counsel & Secretary at AngioDynamics where he led the legal department including compliance and served as Secretary to the Board for this publicly traded medical device company. Previously, he held several roles during his more than ten years at C. R. Bard Inc., including serving as Vice President, Law & Assistant Secretary, and being a Member of the Corporate Management Committee. Other previous experiences include General Counsel roles at other public companies and a leading role at Johnson & Johnson. He is a member of the Director’s Leadership Council at Rutgers Biomedical and Health Sciences and has served as a member of the Rutgers Cancer Institute of New Jersey Director’s Leadership Counsel for 15 years. Richard earned his law degree from Boston University School of Law and holds a Bachelor of Arts, Psychology, from Brandeis University.
